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In Brief
Regulatory T (Treg) cells are essential in
preventing the immune system from
attacking self-tissues. Liu and colleagues
demonstrate that loss of E3 ubiquitin
ligase VHL, a key enzyme responsible for
the degradation of the oxygen sensor
HIF-1a, causes Treg cells to become
inflammatory, leading to massive
inflammatory disease.
Immunity
ArticleE3 Ubiquitin Ligase VHL Regulates
Hypoxia-Inducible Factor-1a to Maintain Regulatory
T Cell Stability and Suppressive Capacity
Jee H. Lee,1 Chris Elly,1 Yoon Park,1 and Yun-Cai Liu1,*
1Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA
*Correspondence: yuncail@liai.org
http://dx.doi.org/10.1016/j.immuni.2015.05.016SUMMARY
Foxp3+ regulatory T (Treg) cells play a critical role in
immune homeostasis; however, the mechanisms to
maintain their function remain unclear. Here, we
report that the E3 ubiquitin ligase VHL is essential
for Treg cell function. Mice with Foxp3-restricted
VHL deletion displayed massive inflammation asso-
ciated with excessive Treg cell interferon-g (IFN-g)
production. VHL-deficient Treg cells failed to prevent
colitis induction, but converted into Th1-like effector
T cells. VHL intrinsically orchestrated such conver-
sion under both steady and inflammatory conditions
followed by Foxp3 downregulation, which was
reversed by IFN-g deficiency. Augmented hypoxia-
inducible factor 1a (HIF-1a)-induced glycolytic re-
programming was required for IFN-g production.
Furthermore, HIF-1a bound directly to the Ifng pro-
moter. HIF-1a knockdown or knockout could reverse
the increased IFN-g by VHL-deficient Treg cells and
restore their suppressive function in vivo. These find-
ings indicate that regulation of HIF-1a pathway by
VHL is crucial to maintain the stability and suppres-
sive function of Foxp3+ T cells.
INTRODUCTION
Regulatory T (Treg) cells are a unique subpopulation of CD4+
T cells that play a pivotal role in maintaining immune tolerance
and preventing autoimmunity against self-antigens. The best-
characterized population of Treg cells is manifested by the cell
surface expression of CD25, the interleukin-2 (IL-2) receptor
alpha chain (Sakaguchi, 2000). Treg cells can be divided into
two types: the thymus-derived naturally occurring (tTreg) and
the peripherally inducible Treg (pTreg) cells. The development
and function of tTreg cells is determined by the transcription fac-
tor Foxp3 (Fontenot et al., 2003; Hori et al., 2003). Its mutation
or deficiency is linked to systemic autoimmune diseases in
both mice and humans (Bennett et al., 2001; Brunkow et al.,
2001; Khattri et al., 2003; Wildin et al., 2001). Recently studies
have documented that Treg cells can acquire specific transcrip-
tional factors known to be essential for the differentiation and
function of T helper (Th) cells and suppress different types of
Th cell-mediated immune responses. For example, Treg cell1062 Immunity 42, 1062–1074, June 16, 2015 ª2015 Elsevier Inc.lineage-specific suppression of Th1, Th2, and Th17 cells was
demonstrated through specific transcription factors expressed
in Treg cells including T-bet, IRF4, and STAT3, respectively
(Chaudhry et al., 2009; Koch et al., 2009; Zheng et al., 2009).
However, the molecular mechanisms underlying the mainte-
nance of the Foxp3 expression and Treg cell plasticity remain
largely unclear.
Inactivation or mutation of von Hippel–Lindau (VHL) gene in
humans predisposes to the development of different tumors
including those in kidney, retina, central nervous system, and
the adrenal gland (Kaelin, 2008). It encodes two forms of 18 and
30 kDa and constitutes the essential component of the VHL E3
ubiquitin ligase complex with elongin B/C, cullin 2, and Ring
box protein 1 (Rbx1) (Kamura et al., 1999; Stebbins et al., 1999).
The most well documented substrate of the VHL complex is
hypoxia-inducible factor 1a (HIF-1a), an oxygen sensor and
transcription factor that controls the expression of various genes
responsible for angiogenesis and glucose metabolism under
low oxygen level (Semenza, 2007). Under normoxic conditions,
HIF-1a is kept at low level, via the hydroxylation by prolyl hydrox-
ylase domain (PHD) enzymes, the recognition and ubiquitination
by VHL, followed by the degradation by the proteasome. Hypoxia
reduces the activity of PHDenzymes,which leads to the accumu-
lation of HIF-1a and the initiation of HIF-1a-dependent transcrip-
tional program. Earlier studies documented that upregulation of
HIF-1a is linked to the innate immunity via the NF-kB pathway
(Rius et al., 2008) and is essential for myeloid cell-mediated
inflammation (Cramer et al., 2003). Interesting, two recent studies
have demonstrated that HIF-1a plays a critical role in the Th17/
Treg cell balance (Dang et al., 2011; Shi et al., 2011). However,
studies from other groups showed that hypoxia/HIF-1a pathway
positively regulates Foxp3 induction (Ben-Shoshan et al., 2008;
Clambey et al., 2012). One critical question remains whether
the E3 ligase component VHL is involved in the regulation of
Treg cells. To address this issue, we generated Vhlfl/fl Foxp3cre
mice to selectively delete VHL expression in Treg cells and
demonstrated that VHL plays an important role in maintaining
Tregcell stability and functionviamodulating theHIF-1apathway.
RESULTS
VHL Deficiency in Treg Cells Leads to Th1
Cell-Dominant Autoimmunity
To examine the role of VHL in regulatory Foxp3+ T cells, we
generated conditional VHL deletion by crossing Vhlfl/fl and
Foxp3cre mice. The conditional knockout mice showed sign of
illness, were not able to gain weight (Figures 1A), and eventually
Figure 1. Vhlfl/fl Foxp3cre Mice Develop
Autoimmunity
(A) Growth curve of Vhlfl/fl Foxp3cre mice. Body
weight was measured.
(B) Survival curve of Vhlfl/fl Foxp3cre mice is shown.
**p < 0.01 (Gehan-Breslow-Wilcoxon test).
(C) H&E stained liver and lung sections.
(D) Expression of CD44 and CD62L in CD4+ T cells
from the spleen and lymph nodes. A representative
dot plot (left panel) and combined plot (right panel)
are shown.
(E) IFN-g and IL-17 expression from CD4+ T cells.
Cells were stimulated with PMA and ionomycin for
4 hr before intracellular staining.
(F) Foxp3 expression from CD4+ T cells was
assessed by flow cytometry.
(G) Distribution of Foxp3, Th1 (IFN-g+IL-17) and
Th17 (IL-17+IFN-g) cells from several organs was
shown.Representativeof at least three independent
experiments. Combined plots for (A) (n = 811), (B)
(n = 9), (D) (n = 1113), and (G) (n = 48) are shown.
Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p <
0.001 (Student’s t test). See also Figure S1.died at 6 to 11 weeks of age (Figure 1B). These mice showed
increased infiltrates in the lung and liver (Figure 1C). A compre-
hensive biochemical analysis using mouse sera showed higher
levels of alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) and reduced glucose and creatinine concen-
tration in Vhlfl/fl Foxp3cre mice (Figure S1A). Even though the
numbers of T cells were not altered in conditional VHL knockout
mice (Figure S1B), we found that activated/memory-type-asso-
ciated CD44highCD62Llow conventional CD4+ and CD8+ T cell
population was notably increased in Vhlfl/fl Foxp3cre mice (Fig-
ures 1D and S1C). B cells also expressed higher level of CD69
(data not shown). Moreover, among effector T cells, Th1 cells
were greatly induced in Vhlfl/fl Foxp3cre mice, but not Th17 cells
(Figure 1E). Foxp3+ cells were slightly reduced in lymph nodes,
but not in the spleen (Figures 1F and S1D). We further examined
the distribution of Foxp3+, Th1, and Th17 cells from severalImmunity 42, 1062–107organs and found that Foxp3 expression
was reduced in lymph nodes, Peyer’s
patches, and small and large intestines,
but not in the liver, lung, and spleen (Fig-
ure 1G). Interestingly, Th1 cells from Vhlfl/fl
Foxp3cre mice were increased in almost
all organs regardless of the levels of
Foxp3 expression, but Th17 cells were
not altered, or only slightly changed.
These results implied that VHL-deficient
Foxp3+ cells are defective in their func-
tions, thereby inducing the activation
of conventional T cells, particularly Th1
cells, and subsequent inflammation.
VHL-Deficient Treg Cells
Showed Impaired Suppressive
Function In Vivo
To investigate the effect of VHL deficiency
on the biological function of Treg cells,we performed in vitro suppression assay. We prepared VHL-
deficient Treg cell by sorting YFP+ cells and then confirmed the
expression level of Foxp3 to an equivalent degree by intracellular
staining (Figure S2A). VHL-deficient Foxp3+ cells were compara-
ble toWT Foxp3+ cells in the suppression of proliferation of naive
T cells in vitro (Figure S2B). We further examined the suppressive
activity in vivo by utilizing an adoptive transfer mouse model
of colitis. VHL-deficient Treg cells failed to prevent the loss of
body weight caused by naive T cells in Rag1/mice (Figure 2A).
Histologic examination of the distal colon indicated that lympho-
cyte infiltrates were increased and showed mucosa hyperplasia
in mice adoptively transferred with VHL-deficient Treg cells (Fig-
ure 2B). VHL-deficient Treg cells were unable to inhibit the induc-
tion of T cells, particularly Th1 cells (Figures 2C, S2C, and S2D).
Whereas the frequency of Th1 cells was not changed, that of
Th17 cells was increased from WT Treg cell-treated Rag1/4, June 16, 2015 ª2015 Elsevier Inc. 1063
Figure 2. VHL Deficiency Leads to the Loss
of Function by Treg Cells
(A) Clinical colitis progression was assessed by
body weight loss. CD45.1+ naive T cells alone or
together with sorted WT or VHL-deficient CD45.2+
Treg cells were adoptively transferred into Rag1/
mice.
(B) Representative images of distal colon after
H&E staining (left panel) and histological analysis
(right panel).
(C) The absolute number of IFN-g+IL-17, IFN-
g+IL-17+ or IFN-gIL-17+ cells differentiated from
transferred naive T cells (CD45.1+). CD4+ T cells
from the spleen, mesenteric lymph nodes (MLN),
and large (L) intestines were examined.
(D) Expression level of Foxp3 and CD103 from
transferred Treg cells (CD45.2+) was analyzed
by intracellular staining. Representative of two
independent experiments. Combined plots for
(A) (n = 45), (B) (n = 45), (C) (n = 45) and (D)
(n = 45) are shown. Error bars indicate SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
See also Figure S2.mice (Figure S2F). While WT Treg cells still maintained the
expression of Foxp3 and CD103, a marker for suppressive
activity and migratory capacity to mucosal area, VHL-deficient
Treg cells lost most Foxp3 expression at 8 weeks after adoptive
transfer (Figures 2D and S2E). Our results demonstrated that
VHL-deficient Treg cells have defects in suppressive activity
in vivo with less stability of Foxp3 and a failure in the suppression
of Th1 induction.
Conversion into IFN-g-Producing Th1 Cells by VHL
Ablation in Treg Cells
To gain the insight into the impaired suppressive activity in vivo in
Vhl/ Treg cells, we examined the expression of key Treg cell
markers including CD25, CTLA4, CD39, CD73, CD44, CD69,
and GITR. Expression levels of those markers by VHL-deficient
Treg cells were comparable to those from WT Treg cells1064 Immunity 42, 1062–1074, June 16, 2015 ª2015 Elsevier Inc.(Figure S3A). Rather, the expression of
CTLA4, GITR, and CD39 were slightly
increased in VHL-deficient Treg cells.
We next examined the expression of heli-
os and Nrp-1 in VHL-deficient Treg cells
to distinguish different Treg cell subpopu-
lations. We found that both helios+ and
helios Foxp3+ cells were reduced in
Vhlfl/fl Foxp3cre mice. Similarly, Nrp-1+
and Nrp-1 Foxp3+ cells were decreased
by VHL deficiency (data not shown). Inter-
estingly, Foxp3helios+ or Foxp3Nrp+
T cells were increased in Vhlfl/fl Foxp3cre
mice (Figure S3B).
It is possible that the impaired suppres-
sion is caused by either defective pro-
liferation or enhanced apoptosis of
VHL-deficient Treg cells. Ki-67 expression
was slightly increased in VHL-deficient
Foxp3+ cells (Figure S3C). However,Foxp3 cells expressed higher level of Ki-67 from Vhlfl/fl Foxp3cre
mice. This could be due to impaired Treg cell functions, which
augmented non-Treg cells proliferation. Next, the homeostatic
proliferation in vivo was assessed by an adoptive transfer of
Violet-labeled Treg cells into Rag1/ mice. VHL-deficient Treg
cells did not show any defect in their proliferation in vivo (Fig-
ure S3D). However, they lost Foxp3 expression after cell division.
To determine the apoptosis of Foxp3+ cells, we stained Treg
cells with annexin V. Apoptotic VHL-deficient Treg cells are
comparable to WT Treg cells (data not shown). In addition, to
examine apoptosis of Treg cell in vitro, isolated Foxp3+ (YFP+)
cells were activated and stained with annexin V and propidium
iodide (PI). Annexin V+ apoptotic cells were rather decreased
in VHL-deficient Foxp3+ cells (data not shown). Therefore, it is
unlikely that the impaired functions of VHL-deficient Treg cells
were caused by altered cell proliferation or enhanced cell death.
Figure 3. Conversion of VHL-Deficient Treg Cells into IFN-g-Produc-
ing Effectors
(A) Cytokine and chemokine production from activated VHL-deficient Foxp3+
cells. Sorted Treg cells were activated by anti-CD3/28 antibodies for 48 hr. The
culture supernatants were harvested and analyzed by Bio-plex assay.
(B) IFN-g and IL-17 expression in Foxp3+ T cells from Vhlfl/fl Foxp3cre mice.
Cells were stimulated with PMA and ionomycin for 4 hr before intracellular
staining.
(C) The conversion of transferred Treg cells (CD45.2+) into IFN-g or IL-17 ex-
pressing cells was determined from colitis mice. CD4+CD45.2+ Cells were
analyzed by intracellular staining at 7 weeks after adoptive transfer. Combined
plots for (B) (n = 89) and (C) (n = 45) are shown. Error bars indicate SEM.
*p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test). Representative of two or
three independent experiments are shown. See also Figure S3.To explore whether the loss of function is due to the plasticity
of VHL-deficient Foxp3+ cells, we screened the production of
several inflammatory cytokines and chemokines after activation
in vitro. Surprisingly, VHL-deficient Foxp3 cells were able toproduce higher levels of cytokines and chemokines such as
interferon-g (IFN-g), IL-10, GM-CSF, IL-4, MIP-1a, MIP-1b,
RANTES, and TNF-a (Figure 3A). VHL-deficient Foxp3+ cells
were also able to produce large amounts of IFN-g, but not
IL-17, in vivo (Figures 3B and S3E). Similar to Th1 cells, VHL-defi-
cient Foxp3+ cells displayed T-bet and CXCR3 expression
(Figures S3F and S3G). We also observed that transferred
VHL-deficient Foxp3+ cells in the colitis mice efficiently pro-
duced IFN-g (Figures 3C and S2G). These results demonstrated
that Treg cells had a tendency to become IFN-g-producing
effector T cells in vitro and in vivo in the absence of VHL.
An Intrinsic Role of VHL in the Conversion
into IFN-g-Producing Effector Cells
To investigate whether the effect of VHL is Treg cell intrinsic, we
generatedmixed bonemarrow (BM) chimeric mice by adoptively
co-transferring WT (CD45.1) BM, as well as BM (CD45.2), from
Vhlfl/fl Foxp3cre mice into irradiated Rag1/ mice. Unlike Vhlfl/fl
Foxp3cre mice, BM mixed chimera mice did not show the acti-
vated CD44highCD62Llow phenotype by either CD45.2 or
CD45.1 T cells (Figure 4A). However, the frequency of VHL-defi-
cient Foxp3+ cells wasmuch lower than theWT counterpart (Fig-
ure 4B). Nevertheless, VHL-deficient Foxp3+ cells were still able
to express IFN-g (Figure 4C). These data suggest that WT
Foxp3+ cells could restore the impaired suppression by VHL-
deficient Foxp3+ cells. Moreover, VHL-deficient Treg cells were
still capable of producing IFN-g even in the presence of func-
tional WT Treg cells.
One issue with the mixed BM chimeric mouse model was that
the mice were lymphopenic in nature, which might affect the
proper development/function of the Treg cells. To address this
issue, we utilized female Vhlfl/fl Foxp3WT/cre heterozygote mice
in which only half of the Treg cells carry a functional cre expres-
sion, and examined the intrinsic phenotype of VHL-deficient Treg
cells. These mice did not develop inflammatory responses.
Because most Treg cells from spleen are tTreg cells, we
examined the Treg cells using anti-CD25 and anti-neuropilin-1
(Nrp-1) antibodies. Both YFP+ and YFP cells still expressed
Foxp3, with a slight reduction of Foxp3 in YFP+ population
from Vhlfl/fl Foxp3WT/cre (Figures 4D and 4E). The frequency of
YFP+ cells among total Foxp3+ T cells was reduced in lymph
nodes, but not in the spleen, fromVhlfl/fl Foxp3WT/cre (Figure S4A).
This suggests that under steady and lympho-replete conditions,
VHL-deficient Treg cells are prone to lose Foxp3. However,
IFN-g production by YFP+ cells was much higher than that by
YFP cells from Vhlfl/fl Foxp3WT/cre mice (Figure 4F), suggesting
that VHL-deficient Treg cells are able to undergo the conversion
into IFN-g-producing Th1-like cells even under non-inflamma-
tory conditions.
We found that Ki-67 expression from VHL-deficient Treg cells
was not affected in female Vhlfl/fl Foxp3WT/cre mice (Figure S4B)
but was reduced in mixed BM chimeric mice (Figure S4C).
This might suggest that the proliferation of VHL-deficient Treg
cells is regulated under certain non-inflammatory conditions.
However, we still found that the emergence of Foxp3Nrp-1+
or Foxp3Helios+ populations from not only mixed BM chimera
mice but also female Vhlfl/fl Foxp3WT/cre heterozygote mice (Fig-
ures S4D and S4E). We also observed increased Foxp3Nrp-1+
population from VHL-deficient Treg cells after transfer intoImmunity 42, 1062–1074, June 16, 2015 ª2015 Elsevier Inc. 1065
Figure 4. VHL Plays an Intrinsic Role in Treg Cell Conversion
(A) Bone marrow (BM) cells from WT (CD45.1) and either WT (CD45.2) or Vhlfl/fl Foxp3cre (CD45.2) mice were adoptively co-transferred into irradiated Rag1/
mice. Eight weeks after adoptive transfer, the expression of CD44 and CD62L by splenic CD4+ T cells was determined.
(B) Development of WT and VHL-deficient Foxp3+ T cells. Foxp3 expression was examined by intracellular staining.
(C) IFN-g and IL-17 expression from WT and VHL-deficient Treg cells in the spleen from BM chimera mice. Foxp3+ cells were gated for analysis by FACS
(left panel) and the percentage of IFN-g+ T cells was calculated (right panel).
(legend continued on next page)
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Rag1/ mice (Figure S4F). The level of HIF-1a expression was
higher in Nrp-1+Foxp3 population from Vhlfl/fl Foxp3WT/cre
mice, but not from control Vhl+/+ Foxp3WT/cre mice, supporting
that those populations had expressed Foxp3 (Figure S4G).
These results support that the notion that the reduction of
Foxp3+ cell numbers was mainly due to the conversion of VHL-
deficient Treg cells into Th1-like cells. Expression of CD25 and
CTLA4 from YFP+Foxp3+ cells was similar to YFPFoxp3+ cells
in female Vhlfl/fl Foxp3WT/cre heterozygote mice (Figure S4H),
suggesting that the expression of Treg cell markers in VHL-defi-
cient Foxp3+ cells was not due to inflammatory responses in
conditional VHL knockout mice (Figure S3A). Taken together,
the data suggested that the conversion of VHL-deficient Treg
cells into IFN-g-producing cells could impair Treg cell function
and downregulate Foxp3 expression regardless of inflammatory
responses.
IFN-g Is Responsible for Impaired Function of
VHL-Deficient Treg Cells
Another important issue is whether IFN-g affects impaired Treg
cell function. To address this, we generated Ifng/ Vhlfl/fl Foxp3-
cre mice. These double knockout mice showed reduced inflam-
matory phenotype in multiple organs (Figures 5A and S5A),
and decreased T cell activation (Figure 5B), compared to
conditional VHL knockout mice. The expression of Foxp3 was
maintained as WT mice (Figure 5C). We further examined the
suppressive activity of Ifng/ Vhl/ Treg cells in a murine colitis
model. Ifng/ Vhl/ Treg cells suppressed autoimmunity in the
colon and prevented from body weight loss (Figures 5D–5G and
S5B). Foxp3 expression was maintained in Ifng/ Vhl/ Treg
cells in contrast to Vhl/ Treg cells (Figure 5H). Similarly, Ifng/
Treg cells were able to suppress colitis development in Rag1/
mice (Figure S5C). These results implicate that IFN-g is most
likely responsible for the impaired suppressive activity in VHL-
deficient Treg cells.
We next examined whether VHL-deficient Treg cells are in-
flammatory by themselves, because VHL-deficient Treg cells
were able to convert into Th1-like effector cells. To address
this possibility, only tTreg cells from WT or VHL-deficient
mice were adoptively transferred into Rag1/ mice to monitor
body weight changes. We found that mice carrying VHL-defi-
cient Foxp3+ cells did not gain body weight (Figure 5I). The pro-
gression of colitis was abrogated by injection with neutralizing
anti-IFN-g antibodies (Figures 5I and S5D and S5E). Impor-
tantly, the phenotypes such as Foxp3 loss and IFN-g induction
from VHL-deficient Treg cells were partially reversed by
neutralizing anti-IFN-g antibodies (Figures S5F and S5G). To
examine whether IFN-g produced by VHL-deficient Treg cells
affects Th1 differentiation from naive T cells, we utilized condi-
tioned medium from cultured VHL-deficient Treg cells in vitro.
The cultured supernatants from Vhl/ Treg cells were efficient
to induce Th1 polarization, whereas those from WT or Ifng/
Vhl/ Treg cells were not (Figure S5H). This implied that(D and E) Foxp3 expression by YFP and YFP+ Treg cells in CD25+Nrp-1+ cells fro
YFP+ and YFP Treg cells is shown in (E).
(F) IFN-g and IL-17 expression by YFP and YFP+Foxp3+ cells from the splee
Combined plots for (A) (n = 47), (B) (n = 47), (C) (n = 36), (E) (n = 4) and (F)
(Student’s t test). Representative of two independent experiments are shown. SeVHL-deficient Treg cells could induce Th1 immune responses
by producing IFN-g.
Increased HIF-1a Promotes Treg Cell Conversion
into IFN-g+ Effector T Cells
It has been well established that VHL deficiency induces the
accumulation of HIF-1a and the subsequent upregulation of
HIF-1a-inducible genes (Kaelin, 2008). We confirmed the
increased expression of HIF-1a in VHL-deficient Foxp3+ cells
(Figures 6A and S4G). HIF-1a serves as a key transcription factor
for anaerobic glycolysis, angiogenesis, and erythoropoiesis (Se-
menza, 2007). The data derived from quantitative real-time PCR
showed that the expression of all glycolysis enzyme genes
examined were greatly upregulated in VHL-deficient Foxp3+
cells (Figure 6B). To further examine whether the glycolytic re-
programming is required for the conversion of VHL-deficient
Foxp3+ cells, we tested whether 2-DG, an inhibitor of hexoki-
nase, can reverse the effect of VHL deficiency. The production
of inflammatory cytokines and chemokines from VHL-deficient
Foxp3+ cells was blocked by 2-DG (Figures 6C and 6D). These
results implied that glycolytic pathway is necessary for the con-
version of VHL-deficient Treg cells into effector T cells.
A recent study reported that HIF-1a plays an important role in
inducing RORgt transcription by binding to Rorc gene in Th17
cell differentiation (Dang et al., 2011). However, VHL-deficient
Treg cell did not show the induction of RORgt mRNA expression,
but the T-bet and IFN-g expression was highly enhanced from
activated VHL-deficient Treg cells (Figures 7A), as well as freshly
isolated VHL-deficient Treg cells (data not shown). Because
Th17 cells are enriched in intestines, due to a Th17 skewing con-
dition in vivo, we examined IL-17 expression by intestinal Treg
cells. As expected, WT Foxp3+ cells from intestines expressed
certain level of IL-17, whereas VHL-deficient Foxp3+ cells ex-
pressed less IL-17 and more IFN-g (Figure S3E). To further test
that the accumulation of HIF-1a by VHL deficiency is responsible
the effect of Treg cell conversion, we next examined the effect of
DMOG, a chemical inhibitor for PHD, and found that it caused a
similar effect as VHL deficiency on Treg cells (Figure 7A). It has
been shown that HIF-1a induces IFN-g expression by binding
on the IFN-g promoter in macrophages (Acosta-Iborra et al.,
2009). We next examined whether IFN-g gene could be a direct
target of HIF-1a in Foxp3+ cells. We found that there are several
putative hypoxia-responsive element (HRE) regions in themouse
Ifng gene (Figure 7B). Chromatin immunoprecipitation (ChIP)
assay was performed to determine whether HIF-1a binds onto
HRE regions in the Ifng gene. We found that of the potential
HIF-1a binding sites, I, II, III, and VII HRE regions were detected
to be responsible for HIF-1a binding (Figure 7C). The pattern of
HIF-1a binding was very similar to that with histone H3 (trimethyl
K4) antibodies, which supported the notion that these regions
were in transcriptionally active states. To further verify HIF-
1a-dependent transcriptional regulation, we utilized the HIF in-
hibitor chetomin, which inhibits HIF binding to the transcriptionalm Vhlfl/fl Foxp3WT/cre female mice. A combined plot for Foxp3 expression from
n (left panel) and L. intestine (right panel) of female Vhlfl/fl Foxp3WT/cre mice.
(n = 4) are shown. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001
e also Figure S4.
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Figure 5. IFN-g Is Responsible for Inflammation by VHL Deficiency
(A) Histological images are shown from liver and lung of 7 week-old lfng/ Vhlfl/fl Foxp3cre mice.
(B) CD62L, CD44, and Ki-67 expression from T cells in peripheral lymph nodes were assessed.
(C) Foxp3 expression among CD4+ T cells in peripheral lymph nodes was examined.
(D–H) Colitis development in Rag1/mice after the adoptive transfer of naive T cells with either WT, Vhl/, or Ifng/ Vhl/ Treg cells were shown. Histological
images of distal colon (D) histopathological scores (E), body weight (F), total colonic cell number (G), and Foxp3 expression from transferred Treg cells
(CD4+CD45.2+) in the colon (H) were shown at 7 weeks after cell transfer.
(I) Colitis induction by VHL-deficient Foxp3+ cells alone. Sorted WT or VHL-deficient YFP+ Treg cells were adoptively transferred into Rag1/mice. Neutralizing
aIFN-g antibodies were administrated into themice every week. The disease development wasmonitored for the changes of body weight. Combined plots for (C)
(n = 6), (E) (n = 34), (F) (n = 8), (G) (n = 4), (H) (n = 4) and I (n = 35) are shown. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Student’s t test).
Representative of two independent experiments are shown. See also Figure S5.
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Figure 6. The Role of Glycolytic Pathway for
the Conversion of Treg Cells
(A) HIF-1a expression in Treg cells in the spleen
from Vhlfl/fl Foxp3cre mice. The MFI was measured
by flow cytometry (left panel) and the values were
calculated and a combined plot for A (n = 4) is
shown (right panel).
(B) Gene expression of glycolytic enzymes by VHL
deficiency. qRT-PCR was performed to determine
mRNA levels of the indicated genes. Sorted YFP+
Treg cells from the spleen and lymph nodes were
used.
(C) WT or VHL-deficient pTreg cells were activated
with anti-CD3/28 antibodies and IL-2 in presence
of 2-DG (0.5mM) for 48 hr. Expression of IFN-g and
IL-4 was examined after stimulation with PMA and
ionomycin for 4 hr.
(D) Cell culture supernatants from (C) were
harvested and analyzed for the production of
cytokines and chemokines by Bio-plex. Error bars
indicate SEM. *p < 0.05 (Student’s t test). Repre-
sentative of two or three independent experiments
are shown.coactivator p300, thereby attenuating HIF-dependent transcrip-
tion (Kung et al., 2004). We found that HIF inhibitor was able to
block the induction of IFN-g expression by VHL-deficient Treg
cells (data not shown).
To further confirm a causal role of HIF-1a in mediating VHL
function, we performed shRNA-mediated knockdown assay in
Treg cells. Knockdown of HIF-1a abolished the induction of
IFN-g and Glut1 gene expression by VHL-deficient Treg cells
(Figure 7D). To investigate the effect of HIF-1a overexpression
on IFN-g and Glut1 expression, we used a hydroxylation-defec-
tive triple mutated P402A/P577A/N813A HIF-1a (HIF-1a-TM) for
enhancing their stability. Overexpression of HIF-1a was able
to upregulate IFN-g expression by WT Treg cells (Figure S6A).
To confirm the role of HIF-1a in VHL-deficient Treg cells in vivo,
we generated conditional HIF-1a/VHL double knockout mice.
HIF-1a deficiency in VHL-deficient Treg cells was able toImmunity 42, 1062–107completely restore impaired Treg cell
function by histopathological examination
(Figure 7E).We also found T cell activation
and Th1 induction from Vhlfl/fl Foxp3cre
mice were suppressed by HIF-1a deletion
(Figures 7F and 7G). We did not see any
difference between WT and Hif1afl/fl
Foxp3cre mice (Figures S6B–S6F). More-
over, we tested whether Vhl/ Hif1a/
Treg cells are functional in a colitis model.
As expected, Vhl/ Hif1a/ Treg cells
were suppressive in colitis developments
in contrast to Vhl/ Treg cell (Figures 7H,
S6G, and S6H). Hif1a/ Treg cells were
comparable to WT Treg cells in suppres-
sion of colitis induction (data not shown).
Foxp3 expression from Vhl/ Hif1a/
Treg cells, but not Vhl/ Treg cell, was
stable at 8 weeks after the adoptive trans-
fer (Figure 7I). Of note, we found thatHIF-2a expression in Treg cells was much lower than HIF-1a
(Figure S6I) and the effect of HIF-2amight beminimal. Moreover,
we tested whether hypoxia induces the conversion of Treg cells.
WT mice showed more IFN-g and CXCR3 expression from
both Foxp3+ and Foxp3 cells after exposure to hypoxia in vivo
(Figure S7), suggesting the conversion of Foxp3+ cells into
Th1-like cells is induced under hypoxic conditions. Thus, our
data demonstrated that VHL-deficient Treg cells express IFN-g
through both transcriptional activation by the binding of accu-
mulated HIF-1a to IFN-g gene and HIF-1a-induced glycolytic
metabolic shift.
DISCUSSION
Here we employ a genetic approach to selectively delete VHL in
Treg cells and show that loss of VHL in Treg cells causesmassive4, June 16, 2015 ª2015 Elsevier Inc. 1069
Figure 7. HIF-1a Directly Binds to IFNG Gene in VHL-Deficient Treg Cells
(A) qRT-PCR was performed for determining mRNA levels of the indicated genes. Sorted YFP+ Treg cells from spleen and lymph nodes were activated with anti-
CD3/28 antibodies and IL-2 in presence of a PHD inhibitor, DMOG, for 48 hr.
(B) Structural schematics of IFNG gene with putative hypoxia response elements (HREs). Blue boxes for exon and red boxes for HRE were shown. Consensus
sequences for putative HRE are in red.
(C) Binding of HIF-1a and histone H3 (trimethyl K4) on the IFNG gene. Sorted YFP+ Treg cells were activated with anti-CD3/28 antibodies and IL-2 for 48 hr.
Relative binding activity was normalized by binding in WT cells.
(legend continued on next page)
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multiple tissue inflammation and activation of both Foxp3 and
Foxp3+ CD4+ T cells. VHL-deficient Treg cells produce exces-
sive amounts of IFN-g, with only slight effect on IL-17 produc-
tion. Loss of VHL in these cells results in the defective inhibition
of normal CD4+ T cells, and the conversion into Th1-like patho-
genic T cells. In addition, we show that VHL-deficient Treg cells
exhibit an increased expression of HIF-1a, and the subsequent
upregulation of glycolytic enzymes. At the molecular level, we
show that HIF-1a directly binds to the IFNG gene. Our study
thus indicates VHL as a critical regulator of Treg cell stability
and function by controlling the HIF-1a pathway to produce
IFN-g.
The present study does not seem to reconcile with the previ-
ous two studies describing a reciprocal role of HIF-1a in Th17/
Treg cell balance (Dang et al., 2011; Shi et al., 2011), because
we found that the primary function of VHL is the regulation of
IFN-g production by Treg cells, whereas the effect on IL-17 pro-
duction is quite marginal, with only distinguishable difference in
intestinal Treg cells. This discrepancy might imply a differential
role of HIF-1a in either Treg cell differentiation as revealed by
the two previous studies, or the function and/maintenance in
established Treg cells as presented in the current study. The
increased IFN-g expression is dependent on the HIF-1a-glyco-
lytic pathway, because we found that the expression of HIF-1a
and the HIF-1a-dependent glycolytic enzymes was augmented
in VHL-deficient Treg cells. More importantly, the increased
IFN-g production was repressed by the incubation with glyco-
lytic inhibitor 2-DG. Because HIF-1a is the most well docu-
mented target for VHL E3 ligase complex and HIF-1a plays a
critical role in the glycolytic metabolic reprograming (Kaelin,
2008; Semenza, 2007), our results indeed support the critical
role of VHL in HIF-1a-glycolytic pathway in controlling Treg cell
function. In addition, the demonstration of HIF-1a binding to
the IFN-g gene indicates that VHL regulates IFN-g gene expres-
sion via both an indirect mechanism (glycolytic reprogramming)
and a direct mechanism (transcriptional modification). It has
been reported that the pyruvate kinase M2, which is upregulated
in VHL/ Treg cells, acts as co-activator for HIF-1a to recruit
p300 to activate transcriptional activation of its target genes
(Luo et al., 2011). Although the lack of a significant effect of
VHL on IL-17 suggests that the VHL is not essential for the con-
version of Treg cell into Th17 cells, HIF-1a itself might possess
a unique role in regulating IL-17 expression, which is indepen-
dent of the VHL-mediated degradation.
It is interesting to note the differential levels of Foxp3 expres-
sion in VHL-deficient Treg cells among different tissues, with
normal Foxp3 expression in the spleen, lung, liver, and much
less expression in lymph nodes and lymphoid tissues from
the intestine under normal conditions. This might correlate with(D) Effect of shRNA knockdown for HIF1-a on IFN-g and Glut1 expression from
transduction. Infected Treg cells (mAmetrine+YFP+) were further sorted and activ
(E) Histology of liver and lung from 8-week-old Vhlfl/fl Hif1afl/fl Foxp3cre mice with
(F) CD62L, CD44, and Ki-67 expression in splenic T cells were determined from
(G) IFN-g expression from splenic CD4+ T cells was examined after cells were ac
(H) Colitis induction was examined by weight change after an adoptive transfer
(CD45.2) into Rag1/ mice.
(I) Foxp3 expression from transferred Treg cells (CD4+CD45.2+) was determined b
(n = 3) are shown. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Stude
See also Figures S6 and S7.the oxygen levels among different locations, because lymph
nodes and intestine are known to be more hypoxic (reviewed
in Sitkovsky and Lukashev, 2005). In a sense, the data do not
support the hypothesis that VHL acts as an E3 ligase to promote
VHL-mediated Foxp3 degradation, as previously proposed
(Dang et al., 2011). Rather, the data indicate that VHL is not
essential for Foxp3 expression per se, since we found that Vhl/
Treg cells still lost (or even more) their Foxp3 expression under
inflammatory conditions, whereas Foxp3 expression is slightly
reduced in steady state (in female Vhlf/f Foxp3WT/cremice). There-
fore, it is likely that the loss of Foxp3 expression by VHL defi-
ciency could be accelerated by secondary inflammatory effects.
Importantly, the reduced Foxp3 expression in hypoxic tissues
does not necessarily correlate with the alteration of IFN-g
production. Therefore, these results suggest the existence of
alternative compensatory mechanisms for HIF-1a to induce
Foxp3 degradation in the absence of the E3 ligase component
VHL. One potential candidate is the SIAH E3 ligases that are
responsible for the degradation of PHD, the upstream regulator
and oxygen sensor of HIF pathway (Nakayama et al., 2004). Or
otherwise, the upregulated glycolytic metabolism in VHL-defi-
cient Treg cells might prime them to lose Foxp3 upon secondary
inflammatory stimulation. It should be noted that previous
studies have also documented that hypoxia-HIF plays a positive
role in Foxp3 induction (Ben-Shoshan et al., 2008; Clambey
et al., 2012). However, these findings are not supported by other
studies (Dang et al., 2011; Shi et al., 2011) and even our current
study. One postulation is that the amounts of HIF-1a are tightly
controlled; either excessive increase or decrease may disrupt
the normal metabolic homeostasis, which might result in
different or even opposite genetic phenotypes.
It might be multifactorial for the explanation of impaired
suppressionbyVHL-deficient Tregcells in vivo.We favor thepos-
sibility that they produce inflammatory cytokines and chemo-
kines to induce inflammatory immune responses and this might
facilitate to boost the activation of other immune cells, together
with the loss of Foxp3 in VHL-deficient Treg cells in vivo. In addi-
tion, localization of Treg cells could be another critical factor for
their function in vivo. VHL-deficient Treg cells could upregulate
CXCR3 on their surface similar to Th1 cells. VHL-deficient Treg
cells might thus have different localization and/or migration
capacities, which can affect their suppressive activities. Loss of
VHL in Treg cells might also affect their homeostasis, which can
contribute to the inflammatory responses observed in Vhlfl/fl
Foxp3cre mice. Indeed, metabolic reprogramming is important
in homeostasis of lymphocyte. Glut1-dependent metabolic
changes is required for proliferation both T andBcells (Caro-Mal-
donadoet al., 2014; Jacobs et al., 2008). HIF-1a is responsible for
proliferation or prolonged survival of lymphocytes (Sueoka et al.,VHL-deficient Treg cells. shRNAs were expressed in pTreg cells by retroviral
ated with anti-CD3/28 antibodies and IL-2 for 48 hr.
H&E staining.
Vhlfl/fl Hif1afl/fl Foxp3cre mice.
tivated with PMA and ionomycin for 4 hr.
of naive T cells (CD45.1) and either WT, Vhl/, or Vhl/ Hif1a/ Treg cells
y flow cytometry. Combined plots for (A) (n = 4), (G) (n = 48), (H) (n = 45) and I
nt’s t test). Representative of two or three independent experiments are shown.
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2013; Zouet al., 2013).On thecontrary,HIF-1aalsopromotes cell
death in hypoxic T cells (Carraro et al., 2007). It is likely that ho-
meostasis is partially regulated by VHL, because the proliferation
of VHL-deficient Treg cells was reduced in mixed BM chimera
mice. However, experimental homeostatic proliferation of VHL-
deficient Treg cells was intact in Rag1/mice after an adoptive
transfer in short-termperiod. These results postulate that homeo-
stasis might be apt to be regulated by secondary effects such as
the microenvironments. Nevertheless, whether VHL plays a
direct role in Treg cell homeostasis or an indirect role by affecting
IFN-g production and/or Foxp3 expression awaits further
investigation.
The acquisition of other transcription factors for Th cells by
Treg cells has been recently well documented, such that the
expression of T-bet is required for Treg cell to control Th1
response, Irf-4 for the suppression of Th2 and Stat3 for the
prevention of Th17 response (Chaudhry et al., 2009; Koch
et al., 2009; Zheng et al., 2009). Here we show that loss of the
E3 ligase VHL results in the expression of T-bet and T-bet-driven
IFN-g production, which attributes to the inflammatory re-
sponses in VHL-deficient mice. Though T-bet or IFN-g is
required for Treg cell function (Koch et al., 2009; Koenecke
et al., 2012), the present study supports the previous observa-
tions that IFN-g production by Treg cells induces Th1 responses
and tissue damages (Lu et al., 2010; Oldenhove et al., 2009;
Ouyang et al., 2012). In addition, the loss of Foxp3 expression
under stress or inflammatory conditions might further render
these mutant Treg cells to become pathogenic T cells to cause
auto-inflammatory responses. Although the issue of Treg cell
conversion into pathogenic Treg cells remains an issue of debate
(Miyao et al., 2012; Murai et al., 2009; Rubtsov et al., 2010; Zhou
et al., 2009), the current studymight suggest that VHL is involved
in the stability/maintenance of Treg cells. Deletion of IFN-g was
effective in enhancing Foxp3 stability in this study. It is likely that
VHL ablation induced HIF-1a-dependent production of inflam-
matory cytokines, which could deteriorate Treg cell stability, fol-
lowed by the reduction of Foxp3 expression under inflammatory
conditions, as well as non-inflammatory conditions. Obviously,
the detailed mechanism underlying whether HIF regulation by
VHL is involved in themaintenance of Treg cell stability and path-
ogenic Treg cell-mediated inflammatory responses awaits
further investigation.
The present study establishes a critical role of HIF regulation
by VHL in Treg cell regulation. Several previous studies have
documented hypoxia and HIF expression in T cell activation,
TCR-induce signaling transduction, Th1/Th2 differentiation (re-
viewed in Sitkovsky and Lukashev, 2005), suggesting that this
pathway functions under both normal physiological and inflamed
conditions. It can be envisioned that dynamic changes of the
glycolytic reprogramming due to the alteration of oxygen tension
in normal local microenvironments or inflamed/damaged tissues
will have either beneficial or harmful consequences in T cells. In
addition, it is known that tumor tissues are hypoxic, and such a
low-oxygen environment can in turn promote tumor cell growth
and expansion (the Warburg effect) (Kim and Dang, 2006).
Such hypoxic condition might also affect the T helper and
CD8+ T cells, and probably Treg cells, which together contribute
to the mechanisms of tumor immune response or evasion. The
molecular understanding of VHL-regulated HIF pathway has1072 Immunity 42, 1062–1074, June 16, 2015 ª2015 Elsevier Inc.enabled the development of small molecule inhibitor to poten-
tially harness the bioenergetics for cancer therapy (Buckley
et al., 2012), and further elucidation of T cell metabolism will
have translational implications for immunological/inflammatory
diseases and immune-based cancer treatment.
EXPERIMENTAL PROCEDURES
Mice
Vhlfl/fl, Hif1afl/fl, Ifng/, Rag1/, and CD45.1 congenic mice were purchased
from Jackson Laboratories. Foxp3-cre-YFP mice were from A. Rudensky
(Rubtsov et al., 2008). Vhlfl/fl, Hif1afl/fl, and Ifng/ mice were crossed with
Foxp3-cre-YFP mice to generate Vhlfl/fl Foxp3cre, Vhlfl/fl Foxp3WT/cre, Vhlfl/fl
Foxp3cre, Ifng/ Vhlfl/fl Foxp3cre, or Vhlfl/flHif1afl/fl Foxp3cre in the animal facility
at La Jolla Institute for Allergy and Immunology under an approved protocol.
Six- to eight-week-old mice were used for the experiments.
Cell Isolation and Sorting
Cells were isolated from the spleen and lymph nodes by grinding with 70 mm
Nylon Mesh (Fisher Scientific). For isolation of cells from intestines, we cut
tissues into pieces (3–4 cm) and washed with HBSS medium containing
5 mM EDTA for 5 times to remove epithelial cells. Then, tissues were digested
with type III collagenase (Worthington) for 1 hr at 37Con a rotator. Splenic and
lymph node cells were used for isolation of CD4+ T cells by using CD4+ isola-
tion Kit II (Miltenyi Biotech). Enriched CD4+ T cells were further sorted
for either YFP+ (Foxp3+) T cells or CD25-CD44-CD62L+ naive T cells by
FACSAria (BD Bioscience). Purity of sorted cells was >99%.
Flow Cytometry
Isolated lymphocytes from tissues were stained with aCD44 (IM7), aCD62L
(MEL-14), aCD25 (PC61), aCD69 (H1.2F3), aCD39 (24DMS1), aCD73 (TY/
11.8), aCTLA4 (UC10-4B9), aGITR (DTA-1), aCD4 (RM4-5), aCD8a (53-6.7),
and aNrp-1 (3E12) antibodies. For CXCR3 expression, cells were stained
with aCXCR3 (220803) antibodies and further incubated with biotin anti-rat
IgG2a (MRG2a-83), followed by staining with PE-streptavidin and aCD4
antibodies. For intracellular staining, cells were fixed and permeabilized with
Fixation/Permeabilization buffer (eBioscience), and then further stained with
aFoxp3 (FJK-16 s), aKi-67 (B56), aHelios (22F6), and aHIF-1a (241812)
antibodies. For intracellular staining for cytokines, cells were stimulated with
PMA (10 ng/ml) and ionomycin (1 mM) in presence of GolgiStop (BD Biosci-
ence) for 4 hr at 37C, and then permeabilized and stained with aIFN-g
(XMG1.2) and aIL-17 (TC11-18H10.1) antibodies. Stained cells were analyzed
by FACSCantoII or LSRII (BD Bioscience).
Colitis Induction
Naive (CD4+CD25CD44CD62L+) T cells from the spleen and lymph nodes of
CD45.1 congenic mice were sorted. Foxp3+ (CD45.2+CD4+YFP+) T cells from
Vhl+/+ Foxp3cre, Vhlfl/fl Foxp3cre, Ifng/ Vhlfl/fl Foxp3cre, or Vhlfl/fl Hif1afl/fl
Foxp3cre mice were prepared by cell sorting. For colitis suppression by Treg
cells, naive T cells (4 3 105) together with WT or KO Treg cells (1 3 105)
were adoptively co-transferred intraperitoneally (i.p.) into Rag1/ mice. For
the colitis induction by Treg cell only, sorted WT or VHL-deficient YFP+ cells
(2 3 105) were transferred i.p. into Rag1/ mice. For injection of anti-IFN-g
antibodies into Rag1/ mice, the mice were received 0.3 mg of neutralizing
antibodies every week for 7 weeks. To monitor colitis development, we
measured body weight up to 50 days. The large intestine was processed for
tissue sectioning and H&E staining.
Mixed Bone Marrow Chimera Mice
Bone marrow cells (5 3 106) were obtained from tibia and fibula from WT
(CD45.1) and Vhlfl/fl Foxp3cre mice (CD45.2) were co-transferred intravenously
(i.v.) into irradiated Rag1/ mice. Mice were sacrificed at 8 weeks after BM
transfer.
Homeostatic Proliferation of Treg Cells
Sorted Treg cell (YFP+) cells were prepared by labeling with CellTrace Violet.
Violet-labeled Treg cells (23 105) were adoptively transferred i.v. into Rag1/
mice. To assess the proliferation, we sacrificed mice at day 8 after an adoptive
transfer.
qRT-PCR
Isolation of mRNA from cells was performed by using RNeasy mini kit
(QIAGEN). cDNAs were synthesized by reverse transcriptase (Superscriptase
III, Invitrogen). Quantitative PCR was performed on LightCycler 480. Expres-
sion level was normalized by cyclophilin A or b-actin. The primers used in
qRT-PCR were listed in Table S1.
Chromatin Immunoprecipitation Assay
Activated pTreg cells with anti-CD3/28 antibodies and IL-2 for 48 hr were fixed
with 1% formaldehyde for 10 min at RT. Then, cells were lyzed in lysis buffer
and sonicated by using E220 Focused-ultrasonicator (Covaris). DNA-protein
complex was immunoprecipitated with anti-HIF-1a antibodies (H1alpha67,
Novus Biologicals) or anti-Histone H3 (tri methyl K4) antibodies (ab8580,
Abcam) for overnight. Immunoprecipitated complexes were reverse-cross-
linked and DNA was eluted. Quantitative PCR was performed and analyzed.
PCR primers for qPCR were listed in Table S2.
Statistical Analysis
Gehan-Breslow-Wilcoxon test was used for Kaplan-Meier survival curves. The
other data were analyzed by paired or unpaired t test using GraphPad Prizm 5.
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